The coming months are crucial for the Canadian cannabis industry.
To drive effective actions, better insights were needed – and so Business of Cannabis in partnership with Nanos Research is launching a quarterly public opinion barometer to measure how Canadians understand and view the cannabis industry.
Today, we are releasing the first component of this benchmark research.
Please provide your email address below and we will send you the downloadable results immediately. If you are a member of the media and seek comment on these findings, please contact Blaine Pearson, at bpearson@businessofcannabis.ca or 416-786-3533.
BofC/Nanos Research // Public Opinion Barometer
The coming months are crucial for the Canadian cannabis industry.
To drive effective actions, better insights were needed – and so Business of Cannabis in partnership with Nanos Research is launching a quarterly public opinion barometer to measure how Canadians understand and view the cannabis industry.
Today, we are releasing the first component of this benchmark research.
Please provide your email address below and we will send you the downloadable results immediately. If you are a member of the media and seek comment on these findings, please contact Blaine Pearson, at bpearson@businessofcannabis.ca or 416-786-3533.
Global Medical Cannabis Market Review 2026
A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.
What's covered
Premium Data Packs
Save 15%Pre-register for the Free Report
Be the first to receive the Global Medical Cannabis Market Review 2026 when it publishes in January.
Here’s What You Should Know About Canada’s Emerging Weed Industry
Next PostMarc Lustig, CEO, CannaRoyalty
BofC
Related Posts
Related Posts
Industry Leaders React to Historic Cannabis Rescheduling
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
Cannabis Rescheduling is Here: Trump Signs Executive Order to Move Cannabis to Schedule III
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...
CBD Company Founder Wins £137k Unfair Dismissal Award Amid Cannim Group Collapse
Could Trump Actually Reschedule Cannabis This Time?
‘Blockbuster’ Cannabis Drug To Be Released in 2026
What’s in Store for the Global Cannabis Industry in 2026?
Cannabis Europa Paris
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
CONNECT
Related Posts
Related Posts
Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of...
Inside the Medical Cannabis Police Guidance: Cancards, Driving, and What Patients Need to Know
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public. Its...
UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs' Council has approved the first...
Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework
As Trump's rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany's controversial medical cannabis bill quietly...
Industry Leaders React to Historic Cannabis Rescheduling
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
Recent Posts
Related Posts
Inside Australia’s Medical Cannabis Boom: Prescriptions, Products & Patients
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow...
Overwhelming Majority (80%) of Canadian Cannabis Now Sourced from Legal Distributors in Major Turnaround
Nearly 80% of Canadian’s now source their cannabis solely from the legal market, marking a stark shift away from the...
Could Australia Be the Next Country to Impose Tariffs on Canadian Cannabis?
Australia’s medical cannabis market is thriving, with revenues expected to grow from around US$600m in 2024 to more than US$1.2bn...
MediPharm On the Brink: Shareholder Revolt Reaches Boiling Point as Board Fight for Survival at Canandian Cannabis Giant
A bitter boardroom battle has erupted at MediPharm Labs, one of Canada’s leading pharmaceutical cannabis companies, as investor Apollo Capital...
Tariff Crisis: Israel’s Cannabis Industry Torn in Two as 165% Import Tax Hangs in the Balance
Israel’s cannabis industry is engaged in a heated and divisive showdown as a proposed 165% tax on Canadian cannabis imports,...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags